A global collaboration towards a secure supply-chain or a differentiated manufacturing model are just some of the options ...

New Delhi: Accepting the bioequivalence study report for Type 2 Diabetes Mellitus, the Subject Expert Committee (SEC) ...

The Nifty Pharma index closed on a negative note on Thursday. Shares of Sun Pharmaceutical Industries Ltd.(up 2.11 per cent), ...

India's first quadrivalent influenza vaccine, for the 2025 southern hemisphere season. A quadrivalent vaccine, by covering strains of both influenza A and influenza B, provides broader protection and ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against a new strain of influenza virus. The ...

Zydus Lifesciences to launch VaxiFlu-4 vaccine for 2025 southern hemisphere, offering broad protection against influenza ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against new strain of influenza virus.

Zydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, offering protection against four new ...

Bihar's SHG Plus model empowers rural women through financial inclusion, helping them build homes, educate children and secure their futures.

Zydus on Wednesday announced that it is ready to launch the season’s first India’s Flu protection as per WHO recommended ...

Indian pharma companies urged to diversify beyond U.S. market due to potential 25% tariff, focusing on global expansion for ...